Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS in Acute Traumatic Spinal Cord Injury
NCT06654804Phase 4Recruiting
- Sponsor
- University of Washington
- Start
- Sep 2023
- Primary completion
- Sep 2027
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of perflutren lipid microspheres in traumatic spinal cord injury (TSCI), sponsored by University of Washington. Started Sep 2023; status: recruiting.
02
Drugs
perflutren lipid microspheres
03
Conditions
traumatic spinal cord injury (TSCI)
Beyond the preview
Go deeper on NCT06654804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06654804.